Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(13%)
Results Posted
33%(1 trials)
Terminated
1(13%)

Phase Distribution

Ph not_applicable
6
75%
Ph phase_2
2
25%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
2(25.0%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(3)
Terminated(3)
Other(1)

Detailed Status

Completed3
Withdrawn2
Terminated1
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (25.0%)
N/A6 (75.0%)

Trials by Status

terminated113%
withdrawn225%
active_not_recruiting113%
unknown113%
completed338%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8